Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: benwood who wrote (113416)	11/21/2020 1:33:44 PM
From: benwood	Respond to of 116957

I was fuzzy on this distinction, but no more. The vaccines have shown 95% efficacy which is the standard data point derived from a widespread trial. Vaccine effectiveness will not be known until later. The big difference I was unaware of is the efficacy data is from a population that received the trial vaccine (or placebo) and then finding out who decided to go in and get tested and also tested positive, then calculating the positive case ratio of those who got the vaccine versus those who got the placebo. That means people who chose not to go in but were carriers of the disease who were asymptomatic were not counted as positives. Too bad they didn't just screen the vaccine receivers every week, but apparently that is not done. So that means the trial doesn't show how many people run around as carriers in spite of the vaccine. Oddly, that means a minor swath of people getting the vaccine in a population could actually result in more not less infections nationwide IF (repeat IF) they turn out to be susceptible to becoming carriers, and dispense with social distancing and mask use. THAT little tidbit won't be known for a while (whether vaccine receivers can also be carriers -- even if those who recovered can later be carriers like they can with e.g. mono). The big problem in the US is there is we have a rudderless ship, and so even managing the distribution of the vaccine is likely to have many issues. Gaslighting the reality of virus so naive and gullible people avoid it is one simple minded but extremely effective way to keep their followers from getting upset and their gross negligence for the past 10 months. If you really want to read more about efficacy versus effectiveness: seattletimes.com If you want to hear the psychological end product of all that gaslighting, one real word anecdote: miamiherald.com